SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anaxagoras who wrote (1979)1/22/1998 7:48:00 PM
From: Dr. Voodoo  Read Replies (1) of 7041
 
"...Zonagen's lead product candidate, Vasomax(TM), is an oral pill treatment for male erectile dysfunction. The company also is developing new approaches to contraception, including zona pellucida-based vaccines in collaboration with Schering AG...."

Their seems to be a distinct separation between Vasomax(TM) and Schering AG. This is probably nothing, but I think it's a little creepy, like a few things that seem to get worded strange. I'm probably nuts. (Myron, you can chime in any time.)

Rob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News